Cash Received Pursuant To A Technology Transfer Agreement

Name:	mu_CashReceivedPursuantToTechnologyTransferAgreement
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The reduction in research and development costs under cost sharing arrangement with Nanya to equally share DRAM development costs.

+ Details

Name:	mu_DramResearchAndDevelopmentExpenseReimbursement
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The percentage of common stock by which we recognize our share of earnings or losses from Aptina under the equity method on a two-month lag.

+ Details

Name:	mu_EquityMethodInvestmentCommonStockOwnershipPercentage
Namespace Prefix:	mu
Data Type:	us-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The item represents the period amortization of the difference between the amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and the amount of underlying equity in net assets the reporting Entity has in the investee. A difference can arise between the carrying value of the equity method investment and the value of the Entity's amount of underlying equity in net assets of the investee, for example, from appreciation of certain assets which is not recognized in earnings, but is recognized in other comprehensive income (a separate component of shareholders' equity) by the investee.

+ Details

Name:	mu_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquityAmountAmortizedDuringPeriod
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

This item represents the accelerated amortization of the difference between cost and underlying equity in net assets of the investee at the date of investment due to the gain recognized related to the August 3, 2009 public offering by Inotera.

+ Details

Name:	mu_EquityMethodInvestmentsAcceleratedAmortizationOfDifferenceBetweenCostAndUnderlyingEquityInNetAssets
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Charge to cost of goods sold as a result of abnormally low production levels including seignificantly reduced demand, labor and materials shortages, and unplanned facility or equipment downtime.

+ Details

Name:	mu_IdleFacilityCharge
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.

+ Details

Name:	mu_LicenseRevenueDramProducts
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

+ Details

Name:	mu_LicenseRevenueDramProductsCumulative
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Loss recognized in the period on firm, noncancelable, and unhedged purchase commitments for goods for inventory, measured in the same way as are inventory losses.

+ Details

Name:	mu_LossOnFirmPurchaseCommitmentForGoodsForInventory
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Obligation under Inotera Supply Agreement to purchase a set percentage of Inotera's wafer production under a long-term pricing arrangement.

+ Details

Name:	mu_ObligationToPurchasePercentageOfWaferProduction
Namespace Prefix:	mu
Data Type:	us-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Purchases during the period of DRAM products under the Inotera Supply Agreement.

+ Details

Name:	mu_PurchasesOfDramProductsFromEquityMethodInvestment
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

This item represents disclosure of the amount of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations that constitute a return of investment; these investments are accounted for under the equity method of accounting. This element excludes distributions that are classified as operating activities.

+ Details

Name:	mu_ReturnOfEquityMethodInvestments
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

This item represents disclosure of the amount of dividends or other distributions received paid to third party by unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations that constitute a return of investment; these investments are accounted for under the equity method of accounting. This element excludes distributions that are classified as operating activities.

+ Details

Name:	mu_ReturnOfEquityMethodInvestmentToThirdParty
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Revenue Recognized On Technology Transfer Agreement

+ Details

Name:	mu_RevenueRecognizedOnTechnologyTransferAgreement
Namespace Prefix:	mu
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The percentage of equity interest in subsidiary sold per stock transaction.

+ Details

Name:	mu_SaleOfMajorityEquityInterestInTransaction
Namespace Prefix:	mu
Data Type:	us-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The item represents the difference, if any, between the amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and the amount of underlying equity in net assets the reporting Entity has in the investee. A difference can arise between the carrying value of the equity method investment and the value of the Entity's amount of underlying equity in net assets of the investee, for example, from appreciation of certain assets which is not recognized in earnings, but is recognized in other comprehensive income (a separate component of shareholders' equity) by the investee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 20

-Subparagraph a(3)

+ Details

Name:	us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Paragraph 18

-Subparagraph f

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 20

-Subparagraph a (1)

+ Details

Name:	us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix:	us-gaap
Data Type:	us-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 20

-Subparagraph b

+ Details

Name:	us-gaap_EquityMethodInvestmentQuotedMarketValue
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment losses recognized.

+ Details

Name:	us-gaap_EquityMethodInvestments
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The profit or loss on sales of previously unissued stock by subsidiaries or equity investees made to investors outside the consolidated group that is not reported as operating income. Represents the difference in the parent company's carrying amount of the equity interest in the subsidiary or equity investee immediately before and after the transaction.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section H

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 13

-Subparagraph h

-Article 9

+ Details

Name:	us-gaap_GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_RoyaltyRevenue
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ Details

Name:	us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix:	us-gaap
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Equity Method Investments - 3 (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		5 Months Ended	12 Months Ended				27 Months Ended	3 Months Ended	12 Months Ended			3 Months Ended
	Mar. 03, 2011	Dec. 03, 2009	Sep. 02, 2010	Aug. 30, 2012	Sep. 01, 2011	Sep. 02, 2010	Sep. 03, 2009	Apr. 30, 2010	Jun. 04, 2009 Inotera [Member]	Sep. 01, 2011 Inotera [Member]	Sep. 02, 2010 Inotera [Member]	Sep. 03, 2009 Inotera [Member]	Dec. 04, 2008 MeiYa [Member]	Sep. 01, 2011 MeiYa [Member]	Sep. 02, 2010 MeiYa [Member]
Schedule of Equity Method Investments [Line Items]
Ownership Percentage (in hundredths)										29.70%	29.90%			50.00%	50.00%
Percentage of Inotera's wafer production obligated to purchase (in hundredths)					50.00%
License revenue related to manufacture of stack DRAM products during the period						$ 65	$ 105
Cumulative license revenue related to manufacture of stack DRAM products								207
Reduction in research and development costs under cost sharing arrangement			51		141
Royalty revenue from Nanya for sales of stack DRAM products					25	6
Gain from Inotera stock issuance		56			0	52	0
Inotera amortization remaining to be recognized					74
Inotera amortization in future periods				49
Accelerated Inotera amortization related to Inotera's issuance of shares		33
Purchase of DRAM products from Inotera					641	693
Loss on our purchase commitment under the Inotera Supply Agreement										28
Underutilized capacity charge as a result of Qimonda's default												95
Cash Received Pursuant To A Technology Transfer Agreement									50				50
Revenue Recognized On Technology Transfer Agreement											13	15
Market value of equity interest in Inotera					296
Distribution received from MeiYa	48				48	0	41
Distribution to third party by MeiYa	48
Percentage interest in Aptina sold (in hundredths)							65.00%
Remaining interest in Aptina's common stock without considering convertible preferred shares (in hundredths)					64.00%
Equity method investments			$ 582		$ 483	$ 582				$ 388	$ 434			$ 1	$ 44